Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism

Naringenin-loaded nano-structured lipid carrier fortifies oxaliplatin-dependent apoptosis in HT-29 cell line

(2019) Sina Raeisi et al.   PROCESS BIOCHEMISTRY

Enhanced brain delivery with lower hepatic exposure of lazaroid loaded nanostructured lipid carriers developed using a design of experiment approach

(2018) P. Gadgil et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Endocytic Selective Toxicity of Rhodamine 6G nanoGUMBOS in Breast Cancer Cells

(2018) Nimisha Bhattarai et al.   MOLECULAR PHARMACEUTICS

Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers

(2018) Hamed Hajipour et al.   Artificial Cells Nanomedicine and Biotechnology

Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells

(2018) Shiva Mahmoudi et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment

(2017) Mehdi Sabzichi et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes

(2016) Da Hee Lee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation

(2016) N. Mennini et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Preparation and Characterization of Microemulsions of Myricetin for Improving Its Antiproliferative and Antioxidative Activities and Oral Bioavailability

(2016) Rui Xue Guo et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells

(2016) Akbar Minaei et al.   MOLECULAR BIOLOGY REPORTS

The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines

(2016) M. Fragni et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia

(2016) Eun-Taex Oh et al.   Scientific Reports

Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway

(2015) HAIZHI HUANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Molecular mechanisms underlying anticancer effects of myricetin

(2015) Kasi Pandima Devi et al.   LIFE SCIENCES

Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells

(2015) Jianfang Feng et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung

(2014) Rajani B. Athawale et al.   BIOMEDICINE & PHARMACOTHERAPY

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

(2013) Nicolas Bertrand et al.   ADVANCED DRUG DELIVERY REVIEWS

Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway

(2011) P.A. Phillips et al.   CANCER LETTERS

A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma

(2010) Hiroto Hatakeyama et al.   ADVANCED DRUG DELIVERY REVIEWS

Myricetin Suppresses Invasion and Migration of Human Lung Adenocarcinoma A549 Cells: Possible Mediation by Blocking the ERK Signaling Pathway

(2009) Yuan-Wei Shih et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells

(2009) Miguel López-Lázaro et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS